Sánchez-Chapado M - Search Results

1

Increase in Ischemia-Modified Albumin and Pregnancy-Associated Plasma Protein-A in COVID-19 Patients.

Sanchez BG, Gasalla JM, Sánchez-Chapado M, Bort A, Diaz-Laviada I. Sanchez BG, et al. Among authors: sanchez chapado m. J Clin Med. 2021 Nov 23;10(23):5474. doi: 10.3390/jcm10235474. J Clin Med. 2021. PMID: 34884175 Free PMC article.

2

Expression of functionally active cannabinoid receptor CB1 in the human prostate gland.

Ruiz-Llorente L, Sánchez MG, Carmena MJ, Prieto JC, Sánchez-Chapado M, Izquierdo A, Díaz-Laviada I. Ruiz-Llorente L, et al. Prostate. 2003 Feb 1;54(2):95-102. doi: 10.1002/pros.10165. Prostate. 2003. PMID: 12497582

3

Does obesity modify prostate cancer detection in a European cohort?

Sanchis-Bonet A, Morales-Palacios N, Barrionuevo-Gonzalez M, Ortega-Polledo LE, Ortiz-Vico FJ, Sanchez-Chapado M. Sanchis-Bonet A, et al. Among authors: sanchez chapado m. Cent European J Urol. 2017;70(1):30-36. doi: 10.5173/ceju.2017.881. Epub 2017 Jan 3. Cent European J Urol. 2017. PMID: 28461985 Free PMC article.

4

Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.

Fernández-Martínez AB, Carmena MJ, Arenas MI, Bajo AM, Prieto JC, Sánchez-Chapado M. Fernández-Martínez AB, et al. Histol Histopathol. 2012 Aug;27(8):1093-101. doi: 10.14670/HH-27.1093. Histol Histopathol. 2012. PMID: 22763881

5

Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide.

Jiménez-Jiménez FJ, López-Alvarez J, Sánchez-Chapado M, Montero E, Miquel J, Sierra A, Gutiérrez F. Jiménez-Jiménez FJ, et al. Clin Neuropharmacol. 1995 Jun;18(3):277-9. doi: 10.1097/00002826-199506000-00009. Clin Neuropharmacol. 1995. PMID: 8635187

6

Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.

Fernández-Martínez AB, Collado B, Bajo AM, Sánchez-Chapado M, Prieto JC, Carmena MJ. Fernández-Martínez AB, et al. Mol Cell Endocrinol. 2007 May 30;270(1-2):8-16. doi: 10.1016/j.mce.2007.01.007. Epub 2007 Jan 21. Mol Cell Endocrinol. 2007. PMID: 17434257

7

Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer.

Rodríguez-Berriguete G, Sánchez-Espiridión B, Cansino JR, Olmedilla G, Martínez-Onsurbe P, Sánchez-Chapado M, Paniagua R, Fraile B, Royuela M. Rodríguez-Berriguete G, et al. Cytokine. 2013 Nov;64(2):555-63. doi: 10.1016/j.cyto.2013.09.003. Epub 2013 Sep 21. Cytokine. 2013. PMID: 24063999

8

PI3K pathway and Bcl-2 family. Clinicopathological features in prostate cancer.

Torrealba N, Rodriguez-Berriguete G, Fraile B, Olmedilla G, Martínez-Onsurbe P, Sánchez-Chapado M, Paniagua R, Royuela M. Torrealba N, et al. Among authors: sanchez chapado m. Aging Male. 2018 Sep;21(3):211-222. doi: 10.1080/13685538.2018.1424130. Epub 2018 Jan 9. Aging Male. 2018. PMID: 29316844

9

Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.

Fernández-Martínez AB, Bajo AM, Sánchez-Chapado M, Prieto JC, Carmena MJ. Fernández-Martínez AB, et al. Prostate. 2009 May 15;69(7):774-86. doi: 10.1002/pros.20930. Prostate. 2009. PMID: 19189304

10

Multifunctional role of VIP in prostate cancer progression in a xenograft model: suppression by curcumin and COX-2 inhibitor NS-398.

Fernández-Martínez AB, Bajo AM, Valdehita A, Isabel Arenas M, Sánchez-Chapado M, Carmena MJ, Prieto JC. Fernández-Martínez AB, et al. Peptides. 2009 Dec;30(12):2357-64. doi: 10.1016/j.peptides.2009.09.018. Epub 2009 Sep 20. Peptides. 2009. PMID: 19772879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page